Skip to main content

Serum-Free Media Market Revenue Growth, Demand, Share, Size Estimation and Opportunity Forecast by 2032

 Global serum-free media market has evolved to be an integrative aspect of healthcare procedures by providing most diagnostic laboratory tests equipped with infectious disease, oncology, and genetics. The massively parallel methods that have now transcended media-based cellular diagnostics further allow the sequencing of entire genomes at very low costs and are expected to grow further in the coming years due to the continuous increase in prognostic assessments for a wide range of diseases.

The global serum-free media market was valued at $1,022.4 million in 2021 and is expected to reach $3,920.5 million by 2032, registering a CAGR of 12.73% during the forecast period 2022-2032. The growth in the global serum-free media market is expected to be driven by factors such as the low risk of contamination in the media, rising awareness of media-based diagnostic testing, and significant number of funding for executing research and development.

Global Serum-Free Media Market

 

Recent Developments in the Global Serum-Free Media Market

•    In August 2022, Thermo Fisher Scientific Inc. expanded the cell culture media manufacturing facility in Grand Island, New York, to support the production of new vaccines and biologics. This expansion would support the worldwide media supply and increase the capacity to create high-quality technologies.
•    In May 2022, FUJIFILM Irvine Scientific completed its new bioprocessing innovation and collaboration center in China. The new center would enable local resources and expertise required to optimize cell culture media and workflows to aid the production of vaccines, advanced therapies, and biotherapeutic drug development in China.
•    In September 2021, Bio-Techne Corporation developed a new medium ExCellerate IpsC expansion medium, for IpsC research in regenerative medicine.
•    In April 2021, PromoCell GmbH launched an upgrade to its Keratinocyte Cell Culture Portfolio. The company expanded its improved animal-extract-free Keratinocyte Growth Medium 3 for the standardized isolation and development of juvenile and adult Normal Human Keratinocytes.
•    In March 2021, the company also launched its improved third-generation Melanocyte Cell Culture Portfolio. Melanocyte Growth Medium M3 is a serum-free, bovine pituitary extract (BPE)-free, and phorbol myristate acetate (PMA)-free media formulation.

Demand – Drivers and Limitations

Following are the demand drivers for the global serum-free media market:

•    Low Risk of Contamination as a Demand Driver
•    Launch of innovative products in Serum-Free Media Ecosystem
•    Low reception cost involving small and medium enterprises in comparison to animal derived media

The market is expected to face some limitations too due to the following challenges:

•    Slow Growth Rate in Comparison to Serum-Supplemented Media
•    Requirement of Diverse Cell-Type for Specific Media Formulation

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Global Serum-Free Media Market

Some of the prominent names established in this market are:

Company Type 1: Serum-Free Media Private Industry
•    MP BIOMEDICALS. 
•    HiMedia Laboratories
•    RD Systems, Inc.
•    Sino Biological, Inc.
•    PAN-Biotech.
•    PromoCell GmbH
•    Athena Environmental Sciences, Inc.
•    STEMCELL Technologies Inc.

Company Type 2: Serum-Free Media Public Industry
•    Corning Incorporated
•    Lonza Group AG
•    Merck KgaA
•    Sartorius AG
•    Thermo Fisher Scientific Inc.
•    FUJIFILM Holdings Corporation
•    Danaher.

 

 

Key Questions Answered in Report

  • What is the role of media type in serum-free media, and what are the advantages associated with serum-free media? What is the importance of recombinant proteins in cell culture applications?
  • What are the key trends in the global serum-free media market? How is the market evolving, and what is its future scope?
  • What are the major drivers, challenges, and opportunities of the global serum-free media market?
  • What are the key developmental strategies implemented by the key players in the global serum-free media market to sustain the competition of the market? What is the percentage share of each of the key players in different key developmental strategies?
  • What is the regulatory scenario of the global serum-free media market? What are the initiatives implemented by different governmental bodies and guidelines put forward to regulate the commercialization of serum-free media products?

 

BIS Related Studies

Global Recombinant Cell Culture Supplements Market

Comments

Popular posts from this blog

Pharmacogenomics Services Market Dynamics, Competitive Landscape & Forecast to 2031

  BIS healthcare experts have found the pharmacogenomics services industry to be one of the most rapidly evolving and dynamic markets. The global  pharmacogenomics services market  is projected to reach $9,346.8 million by 2031 from $5,060.0 million in 2020, at a CAGR of 5.71% during the forecast period 2021-2031. The market is driven by certain factors, including increasing prevalence of infectious diseases and various types of cancer, increasing adoption of personalized medicine shifting the paradigm from reaction to prevention, increasing rate of adverse drug reaction, and surge in usage of pharmacogenomics for drug discovery and development. Currently, the pharmacogenomics services industry is witnessing an upsurge due to the increasing prevalence of infectious diseases and various types of cancer, increase in adoption of personalized medicine shifting the paradigm from reaction to prevention, increasing rate of adverse drug reaction, and surge in usage of pharmacogen...

Oncolytic Virus Therapies Market is projected to grow at a whopping CAGR of 26.28% over the period 2020-2030

  The global oncolytic virus therapies market is undergoing a significant flux with regard to the advancements that have already taken place and are currently invading the market space. Additionally, with the emergence of virus therapeutics, there is an immense potential for these emerging sub-markets to continue fueling the overall oncolytic virus therapies market. This chapter reviews the significant drivers and restraints that are considerably impacting the dynamicity of the global oncolytic virus therapies market. Due to the ever-rising incidence of cancers, the need for better products and services is becoming more evident. Several key players are aligning their technologies as per the market requirements to provide technologically advanced products and services by adopting inorganic strategies such as agreements, partnerships, and collaborations. The global oncolytic virus therapies market is projected to grow at a whopping CAGR of 26.28% over the period 2020-2030 and reach ...

PP Compound Market for Automotive Industry Open Up New Revenue Opportunities

  The global PP compound market for automotive industry is expected to reach $17,324.8 million by 2031, with a CAGR of 5.6% during the forecast period 2021-2031. The growth in the market is expected to be driven mainly by the need to reduce the weight of vehicles and demand for cheaper products that can be used in automotive parts. Impact of COVID-19 on the Global Polypropylene (PP) Compound Market for Automotive Industry Due to the COVID–19 pandemic, the PP compound market was severely impacted like many other industries. Automotive production in 2020 saw a decline of almost 16% due to the impact of COVID-19. In order to control the spread of the virus, the majority of the countries around the globe imposed stay-at-home orders, which led to the shutting of many manufacturing plants. As the production of vehicles declined, the demand for PP compounds suffered negatively in the year 2020. Market Segmentation Global Polypropylene (PP) Compound Market for Automotive Industry by Applic...